Written answers

Thursday, 25 October 2018

Department of Health

Rare Diseases Strategy

Photo of Lisa ChambersLisa Chambers (Mayo, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

252. To ask the Minister for Health the details of the chair and composition of the technical review committee on rare diseases; and his views on whether a conflict of interest exists between the independent NCPE and the technical review committee. [44418/18]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy. 

Photo of Lisa ChambersLisa Chambers (Mayo, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

253. To ask the Minister for Health the terms of reference for the technical review committee on rare diseases; and the timeline for review. [44419/18]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.